Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pleckstrin homology (PH) domain-containing proteins are a large family of intracellular signaling molecules defined by a conserved structural motif of approximately 120 amino acids that binds specifically to phosphoinositides, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 4,5-bisphosphate (PIP2) (Lemmon, 2008, Nat Rev Mol Cell Biol). This interaction facilitates the recruitment of these proteins from the cytosol to the plasma membrane, which is a critical prerequisite for their activation and participation in downstream signaling pathways like the PI3K/Akt and Ras/MAPK cascades (Scheid et al., 2002, Mol Cell Biol). While well-known members include Akt and BTK, the 'other' category encompasses a wide range of proteins such as GRP1, ARNO, and DAPP1, which regulate diverse processes including vesicular trafficking, cytoskeletal dynamics, and lymphocyte activation (IUPHAR/BPS Guide to Pharmacology). Dysregulation of these proteins is frequently implicated in cancer, where increased PIP3 levels lead to constitutive membrane localization and pro-survival signaling (Mahlknecht et al., 2011, Molecular Cancer). Therapeutic targeting of PH domains using small-molecule inhibitors aims to disrupt this membrane recruitment, though the high structural conservation among the 250+ PH domains in the human proteome presents significant challenges for achieving drug selectivity and minimizing systemic toxicity (UniProt Consortium, 2023).
Competitive inhibition of the PH domain to prevent binding to phosphoinositides (PIP2/PIP3) and subsequent membrane translocation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pleckstrin homology domain-containing proteins (PH domain proteins).